$TGTX you tell a young female MS patient (majority of MS patients) that you have 15.3% chance of losing your hair (alopecia) with teriflunomide vs Ubli 3.3% and then see which medicine they will pick not considering any other fantastic results. This was something they couldn’t really discuss but it matters so much in real life to patients.
3
11
11 Likes